Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerald F X Feeney

Showing results (11-20 of 47) with videos related to

Pageof 5
Sort By:
Addictive Behaviors|August 3, 2022
Improving assessment and progress monitoring in alcohol use disorder: An implementation evaluation of the instant assessment and personalised feedback system (iAx)Chloe Kidd, Jason P Connor, Gerald F X Feeney, et al.
Drug and Alcohol Dependence|December 18, 2010
Validation of the Cannabis Expectancy Questionnaire (CEQ) in adult cannabis users in treatmentJason P Connor, Matthew J Gullo, Gerald F X Feeney, et al.
Addictive Behaviors|October 19, 2020
Additive effectiveness and feasibility of a theory-driven instant assessment and feedback system in brief cannabis intervention: A randomised controlled trialZoë E Papinczak, Jason P Connor, Gerald F X Feeney, et al.
Drug and Alcohol Dependence|March 27, 2012
Development and validation of the cannabis refusal self-efficacy questionnaire (CRSEQ) in adult cannabis users in treatmentRoss McD Young, Matthew J Gullo, Gerald F X Feeney, et al.
Alcohol and Alcoholism (Oxford, Oxfordshire)|February 10, 2006
Combined acamprosate and naltrexone, with cognitive behavioural therapy is superior to either medication alone for alcohol abstinence: a single centres' experience with pharmacotherapyGerald F X Feeney, Jason P Connor, Ross McD Young, et al.
Journal of Addictive Diseases|November 8, 2006
Is acamprosate use in alcohol dependence treatment reflected in improved subjective health status outcomes beyond cognitive behavioural therapy alone?Gerald F X Feeney, Jason P Connor, Ross McD Young, et al.
Journal of Substance Abuse Treatment|February 25, 2019
Machine learning vs addiction therapists: A pilot study predicting alcohol dependence treatment outcome from patient data in behavior therapy with adjunctive medicationMartyn Symons, Gerald F X Feeney, Marcus R Gallagher, et al.
Drug and Alcohol Dependence|October 7, 2021
Development and validation of the Stimulant Refusal Self-Efficacy Questionnaire (SRSEQ) in stimulant users in treatmentAngela Wanigasooriya, Jason P Connor, Ross McD Young, et al.
The Australian and New Zealand Journal of Psychiatry|September 17, 2004
Alcohol dependence: the impact of cognitive behaviour therapy with or without naltrexone on subjective health statusGerald F X Feeney, Jason P Connor, Ross Mc D Young, et al.
The Australian and New Zealand Journal of Psychiatry|September 13, 2002
Cognitive behavioural therapy combined with the relapse-prevention medication acamprosate: are short-term treatment outcomes for alcohol dependence improved?Gerald F X Feeney, Ross Mc D Young, Jason P Connor, et al.
Pageof 5

Showing results (11-20 of 47) with videos related to

Sort By:
Pageof 5
Addictive Behaviors|August 3, 2022
Improving assessment and progress monitoring in alcohol use disorder: An implementation evaluation of the instant assessment and personalised feedback system (iAx)Chloe Kidd, Jason P Connor, Gerald F X Feeney, et al.
Drug and Alcohol Dependence|December 18, 2010
Validation of the Cannabis Expectancy Questionnaire (CEQ) in adult cannabis users in treatmentJason P Connor, Matthew J Gullo, Gerald F X Feeney, et al.
Addictive Behaviors|October 19, 2020
Additive effectiveness and feasibility of a theory-driven instant assessment and feedback system in brief cannabis intervention: A randomised controlled trialZoë E Papinczak, Jason P Connor, Gerald F X Feeney, et al.
Drug and Alcohol Dependence|March 27, 2012
Development and validation of the cannabis refusal self-efficacy questionnaire (CRSEQ) in adult cannabis users in treatmentRoss McD Young, Matthew J Gullo, Gerald F X Feeney, et al.
Alcohol and Alcoholism (Oxford, Oxfordshire)|February 10, 2006
Combined acamprosate and naltrexone, with cognitive behavioural therapy is superior to either medication alone for alcohol abstinence: a single centres' experience with pharmacotherapyGerald F X Feeney, Jason P Connor, Ross McD Young, et al.
Journal of Addictive Diseases|November 8, 2006
Is acamprosate use in alcohol dependence treatment reflected in improved subjective health status outcomes beyond cognitive behavioural therapy alone?Gerald F X Feeney, Jason P Connor, Ross McD Young, et al.
Journal of Substance Abuse Treatment|February 25, 2019
Machine learning vs addiction therapists: A pilot study predicting alcohol dependence treatment outcome from patient data in behavior therapy with adjunctive medicationMartyn Symons, Gerald F X Feeney, Marcus R Gallagher, et al.
Drug and Alcohol Dependence|October 7, 2021
Development and validation of the Stimulant Refusal Self-Efficacy Questionnaire (SRSEQ) in stimulant users in treatmentAngela Wanigasooriya, Jason P Connor, Ross McD Young, et al.
The Australian and New Zealand Journal of Psychiatry|September 17, 2004
Alcohol dependence: the impact of cognitive behaviour therapy with or without naltrexone on subjective health statusGerald F X Feeney, Jason P Connor, Ross Mc D Young, et al.
The Australian and New Zealand Journal of Psychiatry|September 13, 2002
Cognitive behavioural therapy combined with the relapse-prevention medication acamprosate: are short-term treatment outcomes for alcohol dependence improved?Gerald F X Feeney, Ross Mc D Young, Jason P Connor, et al.
Pageof 5